Subscribe
Healthcare

FDA advisers recommend Pfizer vaccine for children ages 5 to 11

By Elizabeth Faddis
Published
Add Washington Examiner on Google
FDA advisers recommend Pfizer vaccine for children ages 5 to 11

Advisers to the Food and Drug Administration recommended on Wednesday that children ages 5 to 11 receive the Pfizer-BioNTech vaccine.

The FDA’s advisory committee announced the decision after a study found that the benefits for children who receive inoculation far outweigh the potential risks of cardiac arrest symptoms, according to the Washington Post.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

COVID-19 FDA Pfizer